Jul 13, 2026 08:30AM
Jul 13, 2026 08:30AM
Jun 17, 2026 05:30AM
Jun 16, 2026 10:18AM
Jun 16, 2026 07:00AM
Jun 16, 2026 07:00AM
Jun 1, 2026 08:31AM Edgewise Therapeutics sells sevasemten to Servier for up to $2.65 billion
Jun 1, 2026 08:30AM
May 7, 2026 08:00AM
Mar 10, 2026 07:02AM
Mar 10, 2026 07:00AM
Mar 3, 2026 08:00AM
Feb 26, 2026 08:00AM
Jan 13, 2026 08:00AM Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
Dec 24, 2025 08:00AM
Dec 24, 2025 08:00AM
Dec 22, 2025 07:06AM
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers
Nov 6, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 8, 2025 08:43AM
Aug 7, 2025 10:44AM
Aug 7, 2025 08:00AM
Jul 3, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 10:32AM
Jun 26, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 11, 2025 08:35AM
Jun 5, 2025 08:53AM RBC Capital Reiterates Outperform Rating on Edgewise Therapeutics (EWTX)
May 8, 2025 08:00AM
Mar 11, 2025 08:00AM
Mar 10, 2025 09:44AM
Mar 3, 2025 08:00AM
Jan 13, 2025 12:50PM
Jan 13, 2025 08:00AM
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 16, 2024 06:05AM
Dec 16, 2024 06:00AM
Dec 5, 2024 02:32PM
Dec 5, 2024 02:32PM
Dec 5, 2024 01:02PM
May 9, 2024 08:00AM
Apr 23, 2024 08:02AM Edgewise Therapeutics Inc. (EWTX) Granted EU Orphan Drug Designations for Sevasemten
Apr 23, 2024 08:00AM

326,531 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All